Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04969861 |
| Title | BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Nektar Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA | GRC | AUT |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | United States | Details | |
| Universitätsklinikum Salzburg, Landeskrankenhaus, | Salzburg | Salzburg Bundesland | 5020 | Austria | Details | |
| Attikon University General Hospital | Athens | Attiki | Greece | Details | ||
| ASST Degli Spedali Civili di Brescia | Brescia | Lombardia | Italy | Details |